Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project.
暂无分享,去创建一个
B. Nathwani | D. Weisenburger | J. Armitage | J. Vose | R. Gascoyne | E. Campo | K. Savage | F. Berger | B. Coiffier | N. Harris | K. Maclennan | E. Jaffe | S. Pileri | H. Holte | M. Federico | W. Au | W. Kim | K. Tobinai | T. Rüdiger | Shigeo Nakamura | S. Nakamura | Elaine S. Jaffe | Nancy Lee Harris | H. Holte | Elias Campo | Thomas Rüdiger | Kenneth A. MacLennan | Bharat N. Nathwani | Stefano Pileri | Shigeo Nakamura | Bharat Nathwani | Francoise Berger | Bertrand Coiffier | Won-Seog Kim | Harald Holte | Massimo Federico | W. Y. Au | James O. Armitage | Françoise Berger | Elías Campo | B. Coiffier | Kenneth A Maclennan | S. Pileri | E. Jaffe | M. Federico
[1] Christine F. Wogan,et al. Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] J. Imbert,et al. Peripheral T‐cell lymphoma gene expression profiling and potential therapeutic exploitations , 2010, British journal of haematology.
[3] O. O’Connor,et al. Targeted treatment and new agents in peripheral T-cell lymphoma , 2010, International journal of hematology.
[4] F. Foss. Enhancing existing approaches to peripheral T-cell lymphoma. , 2010, Seminars in hematology.
[5] Enzo Medico,et al. Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] W. Chan,et al. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. , 2010, Blood.
[7] P. Gaulard,et al. Molecular classification of T-cell lymphomas. , 2009, Critical reviews in oncology/hematology.
[8] T. Miller,et al. Localized large cell lymphoma: is there any need for radiation therapy? , 2009, Current opinion in oncology.
[9] B. Martínez-Delgado,et al. Current and future aggressive peripheral T-cell lymphoma treatment paradigms, biological features and therapeutic molecular targets. , 2009, Critical reviews in oncology/hematology.
[10] D. Weisenburger,et al. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] H. Nakamine,et al. Clinico‐pathologic features and outcome of Japanese patients with peripheral T‐cell lymphomas , 2008, Hematological oncology.
[12] Christopher R Flowers,et al. Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States , 2008, Leukemia & lymphoma.
[13] Keunchil Park,et al. Clinical features and prognostic factors of patients with “peripheral T cell lymphoma, unspecified” , 2008, Annals of Hematology.
[14] K. Petráková,et al. Peripheral T-cell lymphoma, unspecified--the analysis of the data from the Czech Lymphoma Study Group (CLSG) registry. , 2007, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.
[15] P. Gaulard,et al. Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma, unspecified: A Groupe d'Etude des Lymphomes de l'Adulte (GELA) study. , 2006, Blood.
[16] S. Pileri,et al. Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] D. Weisenburger,et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. , 2006, Blood.
[18] Y. Kagami,et al. Clinicopathologic and Prognostic Significance of Cytotoxic Molecule Expression in Nodal Peripheral T-Cell Lymphoma, Unspecified , 2005, The American journal of surgical pathology.
[19] N. Schmitz,et al. The International Prognostic Index determines the outcome of patients with nodal mature T‐cell lymphomas , 2005, British journal of haematology.
[20] Y. Kwong,et al. Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.
[21] Y. Yamashita,et al. Clinicopathological features and prognostic factors of Japanese patients with "peripheral T-cell lymphoma, unspecified" diagnosed according to the WHO classification. , 2004, Leukemia research.
[22] R. Gascoyne,et al. Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[23] H. Müller-Hermelink,et al. Nodal peripheral T-cell lymphomas and, in particular, their lymphoepithelioid (Lennert’s) variant are often derived from CD8+ cytotoxic T-cells , 2004, Virchows Archiv.
[24] E. Iannitto,et al. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. , 2004, Blood.
[25] C. Gasparetto. High-Dose Therapy and Stem Cell Transplantation , 2004 .
[26] D. Morgan,et al. Peripheral T-cell Lymphomas: Clinical Features and Prognostic Factors of 92 Cases Defined by the Revised European American Lymphoma Classification , 2003, Leukemia & lymphoma.
[27] R. Pickering,et al. A single-centre study of treatment outcomes and survival in 120 patients with peripheral T-cell non-Hodgkin's lymphoma , 2002, Annals of Hematology.
[28] B. Nathwani,et al. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.
[29] Keunchil Park,et al. Clinical features of peripheral T-cell lymphomas in 78 patients diagnosed according to the Revised European-American lymphoma (REAL) classification. , 2002, European journal of cancer.
[30] A. López-Guillermo,et al. Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.
[31] D. Weisenburger,et al. Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.
[32] P. Gaulard,et al. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA). , 1998, Blood.
[33] B. Nathwani,et al. A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin's lymphoma: a report of the Non-Hodgkin's Lymphoma Classification Project , 1997 .
[34] S. Pileri,et al. Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L. Classification. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.
[35] Emili Montserrat,et al. A predictive model for aggressive non-Hodgkin's lymphoma. , 1993, The New England journal of medicine.
[36] M. Engelhard,et al. Lymphoepithelioid cell lymphoma (Lennert's lymphoma): clinical features derived from analysis of 108 cases , 1993, British journal of haematology.
[37] H. Bartsch,et al. International Agency for Research on Cancer. , 1969, WHO chronicle.
[38] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[39] D.,et al. Regression Models and Life-Tables , 2022 .